Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-25 Tax Withholding |
2023-11-28 4:19 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $0.3821 | 212,471 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $0.77 | 214,396 (Direct) |
View |
| 2023-06-25 Tax Withholding |
2023-06-26 4:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
11,528 | $1.19 | 211,321 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:43 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $1.33 | 222,849 (Direct) |
View |
| 2023-02-25 Tax Withholding |
2023-03-06 5:09 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
9,745 | $2.66 | 487,274 (Direct) |
View |
| 2023-02-24 Option Award |
2023-03-06 5:09 pm |
N/A 2033-02-23 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
318,750 | $0 | 487,274 (Direct) |
View |
| 2022-06-25 Tax Withholding |
2022-06-28 5:25 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
11,525 | $4.31 | 175,816 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 5:17 pm |
N/A 2032-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
219,780 | $0 | 345,364 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:17 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
4,610 | $5.9 | 345,364 (Direct) |
View |
| 2021-06-25 Tax Withholding |
2021-06-29 7:55 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Business Officer |
11,525 | $12.02 | 129,294 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 9:10 pm |
N/A 2031-02-24 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Business Officer |
120,000 | $0 | 220,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:11 pm |
N/A 2030-06-24 |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Business Officer |
300,000 | $0 | 300,000 (Direct) |
View |